FDA Drug Application (208471) for ADLYXIN by SANOFI-AVENTIS US

Back to FDA Applications sponsored by SANOFI-AVENTIS US

Application Number208471
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage0.15MG/3ML (0.05MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameADLYXIN
Active IngredientLIXISENATIDE



Back to FDA Applications sponsored by SANOFI-AVENTIS US